The present invention relates to the use of proton pomp inhibitors in thermal ablation of cancer, and in particular to the use of proton pomp inhibitors encapsulated in liposomes. Furthermore, the invention relates to proton pomp inhibitors in acid solution, encapsulated in liposomes coated with polyethylene glycol or polysaccharides like dextran, and to pharmaceutical formulations containing them.
PHARMACOLOGICAL ADJUVANTS FOR THERMAL ABLATION OF CANCER
CALVITTI MARIO;GIOVAGNOLI STEFANO;LILLI CINZIA;RICCI MAURIZIO;ROSSI CARLO;SCHOUBBEN AURELIE;
2017
Abstract
The present invention relates to the use of proton pomp inhibitors in thermal ablation of cancer, and in particular to the use of proton pomp inhibitors encapsulated in liposomes. Furthermore, the invention relates to proton pomp inhibitors in acid solution, encapsulated in liposomes coated with polyethylene glycol or polysaccharides like dextran, and to pharmaceutical formulations containing them.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
